Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol-Myers Squibb (NYSE: BMY) Delayed: 57.52 +2.13 (3.85%)
Previous Close $55.39    52 Week High $77.12 
Open $55.40    52 Week Low $49.03 
Day High $57.74    P/E 37.35 
Day Low $55.40    EPS $1.54 
Volume 24,000,655       

(NASDAQ: RYZB) Delayed: 62.49 --0 (-0%)
Previous Close $62.49    52 Week High $ 
Open $0.22    52 Week Low $ 
Day High $62.49    P/E N/A 
Day Low $62.49    EPS $ 
Volume 707